In contrast, chip- or bottle-grade PET has a higher molecular weight, with its intrinsic viscosity (IV) generally in the ...
FOX 29 News Philadelphia on MSN
Pennsylvania schools will be required to teach cursive again starting in April
Starting April 12, all public and private schools in Pennsylvania must reintroduce cursive handwriting into their curriculum.
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...
As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...
MedPage Today on MSN
Myeloma Combo With 'Unprecedented' Effect Wins FDA Approval
In second- or later-line setting, combination cut risk of disease progression or death by ...
MedPage Today on MSN
What's the Top Priority for Older Adults With Advanced Cancer?
Study finds that 8% prioritized extending life, while 72% prioritized maintaining QoL ...
Adding belzutifan to standard adjuvant pembrolizumab cut the risk for recurrence or death in patients with resected clear cell renal cell carcinoma.
Median progression-free survival (PFS) in pancreatic neuroendocrine tumor (P-NET) patients was 24.5 months on ...
This article was reviewed by Knox Beasley. Key Takeaways: 1mg oral finasteride effectively treats hair loss and is the ...
From "Generation Shortstop" to a power position that has lost its pop, here's how every area stacks up for 2026.
Investigators are exploring whether combinational therapies can improve survival for patients with renal cell carcinoma or muscle-invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results